Related Experiment Video
Updated: Apr 30, 2026
09:11
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
20.9K
Neferine inhibits Zika virus replication by targeting viral protease
Senfeng Sun1, Tingting Sun2, Xinyu Lei1
1School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Summary
Neferine, a natural compound, effectively inhibits Zika virus (ZIKV) replication by targeting the viral protease. This discovery offers a promising therapeutic strategy for ZIKV and other Flavivirus infections.
Area of Science:
- Virology
- Drug Discovery
- Biochemistry
Background:
- Zika virus (ZIKV), a Flavivirus, causes severe neurological conditions like microcephaly and Guillain-Barré syndrome.
- Current therapeutic options for ZIKV infections are limited, posing a significant public health challenge.
- The ZIKV NS2B-NS3 protease (ZIKVpro) is essential for viral replication and represents a key target for antiviral drug development.
Purpose of the Study:
- To identify and develop inhibitors of the ZIKV NS2B-NS3 protease from natural product sources.
- To evaluate the antiviral efficacy and mechanism of action of potential ZIKV inhibitors.
Main Methods:
- Drug screening using Surface Plasmon Resonance (SPR) against a natural product library.
- Antiviral activity assessment via qRT-PCR, Western blot, and plaque assays.
- Mechanism of action studies including Hydrogen-deuterium exchange mass spectrometry (HDXMS) and Molecular Dynamics (MD) simulations.
Main Results:
- Neferine, a bisbenzylisoquinoline alkaloid from Nelumbo nucifera, demonstrated potent inhibition of ZIKV replication in vitro and in vivo.
- Neferine directly binds to ZIKVpro, inhibiting its catalytic activity by interacting with key residues (Tyr161, Ser135) and disrupting polyprotein processing.
- Neferine exhibited broad-spectrum antiviral activity against Dengue virus, indicating potential as a pan-Flavivirus therapeutic.
Conclusions:
- Neferine shows significant therapeutic potential for treating ZIKV infections.
- The findings provide a strong basis for further development of neferine as an antiviral agent against ZIKV and related Flaviviruses.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:25Arboviral Encephalitis
56
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
56
01:25Inhibitors of Bacterial Protein Synthesis
106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
01:28Inhibitors of Bacterial DNA Synthesis
128
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
128
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
01:15Anthelminthic Agents
102
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
102